Zynga Inc. (NASDAQ: ZNGA) is a leading developer of the world’s most popular social games that are played by more than 100 million monthly consu...
Rite Aid Q4 Earnings Review, Price Target Consensus and Walgreens Merger Status
Overview Rite Aid Corporation (NYSE: RAD) is a national drugstore chain operator. As of March 4, 2017, the company operated 4,536 stores in 31 states ...
Cannabis Company – Aphria Inc. New Joint Distribution Agreement and C$100 Million Capital Raise
Company Overview Aphria Inc. (OTCQB: APHQF) is a Canadian company that produces, supplies, and sells medical cannabis. Pure Nature Wellness Inc. (PNW)...
Invictus MD Strategies Awaiting Canadian Cannabis Legalization
Invictus MD Strategies Corp. (OTCBB: IVITF), is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers und...
GEVO – Debt Restructuring Financial Review and Guidance
Company Overview Gevo, Inc. (NASDAQ: GEVO) is a renewable chemicals and next generation biofuels company headquartered in Englewood, Colorado. The com...
Lot78 Gaining Prominence on the Back of Climate-Responsible Infrastructure
Lot78, Inc. (OTCBB: LOTE) is a business development company based in Connecticut. The Company plans to invest and help grow companies it believes are ...
Gerdau SA (ADR) Analyst Review and Outlook
Gerdau SA (ADR) (NYSE: GGB) Gerdau S.A. (Gerdau) is a manufacturer of long steel in North and South America. The Company is engaged in the production ...
AmpliPhi Biosciences – Phase 2 Development Proposal Receives Positive Feedback from FDA
Company Overview AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biopharmaceutical company engaged in the discovery, development, and commercial...
Liquidmetal Technologies Review of Product Line Financial Results and Guidance
Liquidmetal Technologies Inc (OTCQB: LQMT), is a leading developer of bulk amorphous alloys. Amorphous alloys are unique materials that are distinguis...
(NASDAQ: CBLI) – Entolimod Receives Approval for In Vivo Comparability Study
Company Overview Cleveland BioLabs, Inc. (NASDAQ: CBLI) is a biopharmaceutical company engaged in the development of techniques to activate the immune...